In addition, we found that FSCN1 gene expression was lower in patients with cervical cancer (P < 0.001) (Figure 2A) and head and neck tumors (P < 0.001) (Figure 2B) with PIK3CA alterations than in those in the wild-type group. This evidence concerns the gene FSCN1 and cervical carcinoma.